Agile Therapeutics Inc (STU:0AL)
€ 9.83 0 (0%) Market Cap: 7.41 Mil Enterprise Value: 4.63 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Agile Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 02:10PM GMT
Release Date Price: €4524
Antoine Attali

Good morning, everyone. My name is Antoine Attali, and I'm a member of the JPMorgan Healthcare Investment Banking team. Thank you all for joining us today. It is my pleasure to introduce Al Altomari, Chairman and CEO of Agile Therapeutics. As a reminder, you may submit questions through the ask a question feature on the website of the conference. Al, back to you.

Alfred F. Altomari
Agile Therapeutics, Inc. - Chairman, President & CEO

Great. Thank you, Antoine. I first want to thank Antoine and also Mike Gaito from the JPMorgan Investment Banking team for this invitation and also the conference organizers for giving us a hand.

So I'm thrilled today to be talking about our company because this is such a critical time. And as the investors consider building out their portfolio and putting their bets on the table, I hope you consider Agile Therapeutics as one of those bets you're willing to make. Because like I said, it's a critical time for our company, and we think it's a critical inflection point.

So throughout the presentation,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot